|
upscaling and usage implementation of portable automated peritoneal dialysis (papd) system among end-stage renal disease (esrd) patients in malaysia
|
01-12-202330-11-2026
|
Penyelidik Bersama
|
|
the role of tolvaptan as an early adjunctive therapy in acute decompensated heart failure
|
01-11-202431-10-2026
|
Penyelidik Bersama
|
|
the prevalence, risk factors, and implications of complications related to dialysis catheter insertion at a tertiary centre in malaysia
|
12-09-202411-09-2026
|
Penyelidik Bersama
|
|
predictors of outcome for infective endocarditis in hospital canselor tuanku (hctm); a etrospective study
|
30-05-202429-05-2026
|
Penyelidik Bersama
|
|
the role of tolvaptan as an adjunctive therapy in acute decompensated heart failure
|
26-08-202425-02-2026
|
Penyelidik Bersama
|
|
pregnancy outcomes in chronic kidney disease at a tertiary centre in malaysia
|
13-06-202412-09-2025
|
Penyelidik Bersama
|
|
discover careme global registry: real world data on patient management and quality of care
|
20-05-202119-05-2025
|
Penyelidik Bersama
|
|
evaluating the target attainment frequency of piperacillin and meropenem trough concentrations among the critically ill patients on continuous renal replacement therapy.
|
01-10-202231-03-2025
|
Penyelidik Bersama
|
|
an intelligent ckd detection based on morphological changes in retinal photography
|
01-10-202231-03-2025
|
Penyelidik Bersama
|
|
a multicentre international randomized parallel group double-blind placebo-controlled clinical trial of empagliflozin once daily to assess cardio-renal outcomes in patients with chronic kidney disease
|
13-09-201812-09-2024
|
Ketua Projek
|
|
end stage renal disease patients undergoing haemodialysis in malaysia:associations of gut microbiota, diet, biochemical and chronic systemicinflammatory markers
|
07-09-202106-09-2024
|
Penyelidik Bersama
|
|
a phase 2b randomised, double-blind, placebo-controlled, multi-centre, dose-ranging study of azd5718 in participants with proteinuric chronic kidney disease
|
24-01-202123-01-2024
|
Penyelidik Bersama
|
|
elucidating the dysbiosis of firmicutes/bacteroidetes in the gut in signaling the activation of t regulatory cells, interferon alfa (ifn-α), and interleukin 6(il-6) pathway in patients with systemic lupus erythemathosus (sle).
|
01-11-202031-10-2023
|
Penyelidik Bersama
|
|
randomised, double-blind, placebo-controlled and parallel dose group trial to investigate efficacy and safety of multiple doses of oral bi 690517 over 14 weeks, alone and in combination with empagliflozin, in patients with diabetic and non-diabetic chroni
|
28-02-202227-10-2023
|
Ketua Projek
|
|
associations of the susceptibility gene loci of systemic lupus erythematosus (sle) with renal manifestations and their functional proteins
|
01-08-202031-07-2023
|
Penyelidik Bersama
|
|
utility of intradialytic blood culture in diagnosing catheter related bloodstream infection (crbsi)
|
01-08-202031-07-2023
|
Penyelidik Bersama
|
|
the use of ckd-check to improve physician’s practice in ckd management: a pilot study in primary care setting
|
13-01-202212-07-2023
|
Penyelidik Bersama
|
|
a randomized open label pilot study of probiotics as adjunctive therapy for treatment of sle
|
24-01-202123-04-2023
|
Penyelidik Bersama
|
|
global assessment of acute and chronic kidney disease incidence and outcomes in patients with covid 19 infection
|
25-06-202024-12-2022
|
Ketua Projek
|
|
validity and reliability of patient reported outcome measures sle qol-malay and lupus qol-malay) among sle patients in ukmmc and htar
|
20-05-202119-11-2022
|
Penyelidik Bersama
|
|
comparison of optical coherence tomography angiography parameters between diabetic chronic kidney disease and non-diabetic chronic kidney disease
|
16-01-202015-11-2022
|
Penyelidik Bersama
|
|
covid-19 breakthrough infections among patients with kidney diseases post-covid-19 vaccination
|
23-12-202122-10-2022
|
Ketua Projek
|
|
effect of sodium glucose co transporter 2 (sglt2) inhibition on optical coherence tomography angiography (oct-a) parameters in diabetic chronic kidney disease (ckd)
|
18-12-201917-10-2022
|
Penyelidik Bersama
|
|
comparison of retinal optical coherence tomography angiography parameters between patients with different causes of chronic kidney diseases
|
01-10-201930-06-2022
|
Penyelidik Bersama
|
|
retrospective study on sensitivity and specificity of 1997 acr revised criteria, boston weighted criteria, 2012 slicc classification criteria, and 2019 eular/acr classification criteria in systemic lupus erythematous and links to outcome and mortality
|
03-08-202102-06-2022
|
Penyelidik Bersama
|
|
associations of the common susceptibility risk loci of sytemic lupus erythematosus (sle) with disease manifestations and treatment response.
|
01-01-201931-03-2022
|
Penyelidik Bersama
|
|
laboratory and clinical evaluation of hba1c analysis on abbott architect c enzymatic
|
27-02-202026-01-2022
|
Penyelidik Bersama
|
|
phase 3, randomized, open-label, active-controlled study evaluating the efficacy and safety of oral vadadustat for the maintenance treatment of anemia in subjects with non-dialysis-dependent chronic kidney disease (ndd-ckd) (pro2tect - conversion)
|
18-11-201617-12-2021
|
Penyelidik Bersama
|
|
associations of the malaysian susceptibility gene loci of systemic lupus erythematosus (sle) with lupus nephritis and treatment response
|
11-06-202010-12-2021
|
Penyelidik Bersama
|
|
prevalence of platelet dysfunction and its association with urea level in chronic kidney disease
|
11-06-202010-11-2021
|
Ketua Projek
|
|
late-onset of systemic lupus erythematosus (sle) among the multi-ethnic malaysian cohort in universiti kebangsaan malaysia medical centre
|
26-03-202025-09-2021
|
Penyelidik Bersama
|
|
the association of retinal vessel caliber, tortuosity and macula volume changes with ckd progression in diabetics vs non-diabetics over a one year period
|
12-09-201911-03-2021
|
Ketua Projek
|
|
predictors and outcome of systemic lupus erythematosus hospitalizations in ukmmc: a 10-year retrospective study
|
11-06-202010-02-2021
|
Ketua Projek
|
|
the use of intravenous pamidronate in dialysis patients undergoing parathyroidectomy
|
09-02-201808-02-2021
|
Penyelidik Bersama
|
|
aetiological spectrum of chronic kidney disease in ukm medical centre
|
24-01-201923-01-2021
|
Penyelidik Bersama
|
|
retinal microvasculature and macular changes in patients with chronic kidney disease (ckd): a case control study
|
21-08-201920-01-2021
|
Penyelidik Bersama
|
|
renal survival rate in lupus nephritis patients in ppukm
|
16-01-202015-01-2021
|
Penyelidik Bersama
|
|
maternal and foetal outcomes in pregnant women with underlying ckd in ukmmc
|
25-07-201924-07-2020
|
Penyelidik Bersama
|
|
catheter related blood stream infections and catheter colonisers among dialysis patients in universiti kebangsaan malaysia medical centre (ukmmc): prevalence, risk factors and outcomes
|
26-09-201925-06-2020
|
Ketua Projek
|
|
effects of oral calcitriol in the treatment of biopsy proven immunoglobulin a nephropathy: randomised control clinical study
|
25-09-201824-03-2020
|
Ketua Projek
|
|
progression of kidney disease and cardiovascular outcomes in patients with non-diabetic chronic kidney disease over a four-year period
|
13-09-201812-09-2019
|
Penyelidik Bersama
|
|
access to renal transplantation and post-transplantation prognosis (retrapp) study of adults in malaysia
|
24-12-201723-06-2019
|
Penyelidik Bersama
|
|
comparison of anti c1q antibody levels in lupus nephritis and non-lupus nephritis in systemic lupus erythematosus: a case-control study
|
17-05-201816-05-2019
|
Penyelidik Bersama
|
|
the epidemiology and prognostic factors for mortality in intensive care unit patients with acute kidney injury in southeast asia
|
27-04-201726-04-2019
|
Penyelidik Bersama
|
|
a randomised, open-label, parallel group, multi-centre controlled study to evaluate the clinical performance and safety of stay safe linkr compared with stay safer in patients with end-stage kidney disease on continuous ambulatory peritoneal dialysis (cap
|
26-10-201725-03-2019
|
Penyelidik Bersama
|
|
the efficacy of combination treatment of haemoperfusion and haemodialysis versus haemodiafiltration in removing middle molecule uraemic toxins in end stage renal disease patients
|
12-10-201711-12-2018
|
Penyelidik Bersama
|
|
correlation between serum and urinary interleukin-17 with disease activity in systemic lupus erythematosus (sle)
|
02-11-201530-04-2018
|
Penyelidik Bersama
|
|
efficacy of febuxostat in slowing the egfr decline in diabetic nephropathy and ckd stage 3 and 4 patients with asymptomatic hyperuricemia
|
13-07-201712-04-2018
|
Penyelidik Bersama
|
|
pregnancy outcomes in sle women treated with hydroxychloroquine 10 years retrospective data analysis
|
12-10-201711-04-2018
|
Penyelidik Bersama
|
|
avascular necrosis (avn) among systemic lupus erythematosus (sle) patients and the associated risk factors
|
12-10-201711-04-2018
|
Penyelidik Bersama
|
|
pregnancy in systemic lupus erythematosus (sle) patients : factors associated with disease relapse and adverse pregnancy outcomes
|
28-07-201627-01-2018
|
Penyelidik Bersama
|
|
does correction of metabolic acidosis in chronic kidney disease patients have any beneficial effects ?
|
08-02-201407-02-2016
|
Penyelidik Bersama
|
|
knowledge level and choice of treatment among patients at 4th and 5th stage renal failure in a tertiary hospital
|
03-05-201402-02-2015
|
Penyelidik Bersama
|
|
-
|
11-01-2022
|
Ketua Projek
|